Crown Bioscience, Inc.
This role involves analyzing large-scale biological data for biomarker discovery and drug mechanism investigation while developing AI agents for streamlined workflows. It requires collaborating with research scientists to design experiments and communicating scientific results through technical reports and presentations. Candidates will leverage expertise in bioinformatics, omics data analysis, and large language model applications within an oncology-focused biotechnology environment.
Headquarters
San Diego, California, United States
Company Size
1001-5000 employees
Founded
2006
N/A
Preclinical evidence for the effective use of TL-895, a highly selective and potent second-generation BTK inhibitor, for the treatment of B-cell malignancies
Nov 21, 2023
Narazaciclib, a novel multi-kinase inhibitor with potent activity against CSF1R, FLT3 and CDK6, shows strong anti-AML activity in defined preclinical models
Apr 19, 2024
Comparison of Continuous Glucose Monitoring between Dexcom G4 Platinum and HD-XG Systems in Nonhuman Primates ( Macaca Fascicularis
Aug 29, 2017
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Crown Bioscience, Inc..
Crown Bioscience, Inc. didn’t post a salary, so this is our estimate from similar listings.
12% below the average for this role